Aberrantly expressed MYC, acting as a transcriptional activator (in case of TET1) and a repressor (in case of TET2), deregulates TETs in T-ALL, causing global methylation and hydroxymethylation abnormalities. The gene discussed is MYC; the disease is acute lymphoblastic leukemia.